Komori
Mitsubishi Chemical Group (4188) · TargetBelow full-year forecast

FY2020 consolidated earnings outlook

First written in FY2020. 1 of 5 entries say "Restated". Latest entry: FY2021.

5entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020 – FY2021-Q1SoftenedFY2021-Q2RaisedFY2021-Q32020: 320202021: 22021
Same theme, other companies

The whole theme swung hardest in 2021: 2 of 23 companies on the "Worse" side.

11 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 26 companies compared. The sentences above are computed from all 26.
Full recordFilings, disclosures and news, newest first
  1. FY2021Below full-year forecastAnnual report

    「Revenue was ¥3,257.5 billion, core operating profit was ¥174.7 billion, operating profit was ¥47.5 billion, profit before tax was ¥32.9 billion, profit for the period was ¥22.7 billion, and loss for the period attributable to owners of the parent was ¥7.6 billion.」

    Some metrics exceeded the previous revised forecast, including revenue of ¥3,193.0 billion and core operating profit of ¥153.0 billion, but results were substantially below the FY2020 target and the initial outlook.
  2. FY2021-Q3RaisedAnnual report

    「Revised forecast (B): 31,930 1,530 230 △220 △480」

    For the full-year forecast for the fiscal year ending March 2021, the Company revised revenue from ¥3,175.0 billion to ¥3,193.0 billion, core operating profit from ¥140.0 billion to ¥153.0 billion, operating profit from ¥4.0 billion to ¥23.0 billion, profit for the period from a loss of ¥34.0 billion to a loss of ¥22.0 billion, and profit for the period attributable to owners of the parent from a loss of ¥59.0 billion to a loss of ¥48.0 billion.
  3. FY2021-Q2SoftenedAnnual report

    「Previous forecast (A): Revenue ¥3,334.0 billion, core operating profit ¥140.0 billion, operating profit ¥137.0 billion, profit for the period ¥77.0 billion, and profit for the period attributable to owners of the parent ¥49.0 billion. Revised forecast (B): Revenue ¥3,175.0 billion, core operating profit ¥140.0 billion, operating profit ¥4.0 billion, loss for the period ¥34.0 billion, and loss for the period attributable to owners of the parent ¥59.0 billion.」

    The Company substantially lowered its forecasts for revenue, operating profit, profit for the period and profit for the period attributable to owners of the parent for the fiscal year ending March 2021. The forecast for core operating profit remains unchanged at ¥140.0 billion.
  4. FY2021-Q1RestatedAnnual report

    「There has been no change to the outlook for consolidated results for the current fiscal year from the figures stated in the securities report for the previous fiscal year. The outlook was prepared on the assumption that, although difficult conditions would continue during the current fiscal year while the end of the pandemic remained unforeseeable, results would begin to recover from the third quarter onward, and incorporates risks such as declining demand in each business.」

    The Company has left its earnings outlook for the fiscal year ending March 2021 unchanged, continuing to assume a recovery from the third quarter of the consolidated fiscal year onward and to factor in the risk of declining demand.
  5. FY2020First statedAnnual report

    「For the consolidated results of the following fiscal year, revenue is expected to be ¥3.334 trillion, core operating profit ¥140.0 billion, operating profit ¥137.0 billion, profit before tax ¥114.0 billion, net profit ¥77.0 billion, and profit attributable to owners of the parent ¥49.0 billion.」

    The Company newly presented its earnings outlook for the following fiscal year, based on the assumption that, although the impact of COVID-19 would continue, results would begin to recover from the third quarter of FY2020 onward.
Moved together

"Business and performance risks from the COVID-19 pandemic" moved the same way as this thread, in the same document, in 2 of its 5 moves.

2★1
  1. ★This thread
  2. 1Business and performance risks from the COVID-19 pandemic2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Mitsubishi Chemical Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.